Bayer Aktienges Ads (BAYRY) 149.8900 $BAYRY
Global Myocardial Infarction Pipeline Review 2015
M2 - Thu May 14, 5:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m6sc3q/myocardial) has announced the addition of the "Myocardial Infarction - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Myocardial Infarction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myocardial Infarction and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - A. Menarini Industrie Farmaceutiche Riunite Srl - Alligator Bioscience AB - AstraZeneca PLC - Athersys, Inc. - Bayer AG - CellProthera - Compugen Ltd. - CSL Limited - FibroGen, Inc. - Fina Biotech - Genextra S.p.a. - GlaxoSmithKline plc - GliaMed, Inc. - Hadasit Medical Research Services & Development Ltd - Lacer, S.A. - Lee's Pharmaceutical Holdings Limited - LegoChem Biosciences, Inc - LG Life Sciences, Ltd. - Ligand Pharmaceuticals, Inc. - Medestea Research & Production S.p.A. - Merck & Co., Inc. - Omni Bio Pharmaceutical Inc. - Pluristem Therapeutics Inc. - Polyphor Ltd. - Quantum Genomics SA - Recardio GmbH - Remedy Pharmaceuticals, Inc. - Targazyme, Inc. - Vicore Pharma AB - Zydus Cadila Healthcare Limited For more information visit http://www.researchandmarkets.com/research/m6sc3q/myocardial
PSTI: 2.68 (-0.01), MRK: 60.23 (+0.45), AZN: 69.29 (-0.81), CGEN: 6.45 (-0.03), FGEN: 20.38 (-1.01), GSK: 44.77 (-0.22), ATHX: 1.27 (-0.01)
Research and Markets: Global polyolefins Market 2015-2020 - Application Overview, Trends, Growth, Future, Opportunities, Challenges, Segmentation, Trends & Forecasts
Business Wire - Wed May 13, 9:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7pdr38/global) has announced the addition of the "Global polyolefins Market By Application Overview, Trends, Growth, Future, Opportunities, Challenges, Segmentation, Trends & Forecast 2015-2020" report to their offering.
DOW: 51.51 (+0.27)
Global polyolefins Market 2015-2020 - Application Overview, Trends, Growth, Future, Opportunities, Challenges, Segmentation, Trends & Forecasts
M2 - Wed May 13, 6:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nk9f5s/global) has announced the addition of the "Global polyolefins Market By Application Overview, Trends, Growth, Future, Opportunities, Challenges, Segmentation, Trends & Forecast 2015-2020" report to their offering. Extensive competitive and strategy analysis is covered in this report. Companies profiled include BASF, Dow Chemical Company, Bayer AG, Saudi Basic Industries Corporation (SABIC), LyondellBasell Industries, DuPont, Braskem, Aryasasol among others. The report forecast market growth and trends via applications, technologies and geographies from 2014 -2021. The popularity of polyolefins has been largely motivated due to its extremely diverse applications. Polyolefins are used in industries such as packaging, automotive, transportation, consumables, electronics, building, construction, etc., blow molding that includes blow molded bottles for juice, milk, motor oil, laundry detergents, etc. and fibers and tapes mostly used in building & construction, etc. Another motivating factor is the easy availability of raw materials and the huge demand from China. The growth in the industry is largely driven from packaging and construction industry. The industry has received a huge push from the demand from various sectors and the continuous innovation. Of these, innovations in packaging applications have resulted in adoption of polyolefins packaging materials in a big way. Food packaging that mostly comprises of thin walled containers and films, has found a huge market in both the developed and developing countries. The huge demand in Asia-Pacific market is one of the primary drivers for polyolefins industry. A number of companies have also established their presence in Asia-Pacific to meet the demand primarily from various industries in China. Key Topics Covered: Chapter 1. Executive Summary Chapter 2. Market Overview Chapter 3. Market Determinants Chapter 4. Market Segmentation Chapter 5. Sector Analysis Chapter 6. Competitive Intelligence Chapter 7. Market Share Analysis Chapter 8. Geography Analysis Chapter 9. Corporate Profiling - BASF - Dow Chemical Company - Bayer AG - Saudi Basic Industries Corporation (SABIC) - LyondellBasell Industries - DuPont - Braskem - Aryasasol - Indian Petrochemicals Corporation - Formosa Plastics - Akzo Nobel/Imperial Chemical Industries - Evonik Industries - Asahi Kasei - Toray Industries - Chevron Phillips - PPG Industries - Shin-Etsu Chemical - PTT Group - Cargill - Mitsubishi Chemical - Rogers Corporation - PolyOne Corporation - Lotte Chemical - Total Petrochemical - Hitachi Chemical - Arkema - Lanxess - INEOS For more information visit http://www.researchandmarkets.com/research/nk9f5s/global
POL: 40.19 (-0.50), ROG: 71.36 (+0.02), PPG: 231.70 (+2.90), DOW: 51.51 (+0.27)
Congestive Heart Failure - 2015 Pipeline Analysis Covers Some of the Hot Targets in Research for CHF Treatments
M2 - Mon May 11, 10:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zw4hvv/congestive_heart) has announced the addition of the "Congestive Heart Failure - Pipeline Analysis" report to their offering. Congestive Heart Failure (CHF) Pipeline Analysis gives comprehensive insight on the various drugs being developed for the treatment of CHF. The report covers all the drugs being developed in various development phases (Discovery to Phase 2 clinical). The pipeline focuses on disease modification and includes pharmacologic drugs, gene therapy, stem cell therapy and RNA-based therapeutics, but excludes symptom relief drugs like diuretics, acute treatments, angiotensins or thrombin inhibitors etc. This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative opportunities in the CHF Drug market. The report also provide strategic insights on medicines that are likely to have an impact on CHF treatment space and potentially alter standards of care in CHF in the foreseeable future. Current therapies focuses only to slow down the progression of the disease as more number of molecules are symptom relieving drugs, hence it provides a tremendous opportunity for upcoming therapies specific to CHF such as gene-based, stem cell-based and miRNA-based therapies, which reverses disease course and reduce the number of cardiac events. Companies Mentioned: - Bayer AG - Bioheart, Inc. - Celladon Corp - Coretherapix - Glaxosmithkline - Juventas Therapeutics - Merck & Co. - Miragen Therapeutics - Moderna Therapeutics - Nano Cor Therapeutics - ONO Pharmaceuticals For more information visit http://www.researchandmarkets.com/research/zw...tive_heart About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MRK: 60.23 (+0.45), CLDN: 2.18 (-0.17)
Can-Fite cleared to start CF102 Phase 2 trial in Europe for liver cancer
Seeking Alpha - at Seeking Alpha - Mon May 11, 7:29AM CDT
CANF: 2.33 (-0.01), AMGN: 162.36 (+0.38)
Regeneron Beats, Raises And Accelerates Its Late-Stage Product Development
DoctoRx - at Seeking Alpha - Mon May 11, 7:02AM CDT
PCYC: 255.42 (-0.50), ISIS: 62.55 (+0.10), AZN: 69.29 (-0.81), ABBV: 65.99 (+0.02), SNY: 50.52 (-0.27), REGN: 489.01 (-2.42), NVS: 103.75 (-0.15)
Week In Review: Xinbang Pharma Acquires Chinese Peptide Co. For $323 Million
ChinaBio Today - at Seeking Alpha - Sun May 10, 9:03AM CDT
Deals and Financings Guizhou Xinbang Pharmaceutical (SHE: 002390) paid $323 million to acquire Chinese Peptide Company, located in Hangzhou, from the nine companies that owned it. In addition, Xinbang raised as much as $106 million, which it will...
MACK: 12.66 (+0.34), PVCT: 0.87 (-0.01), CCM: 7.01 (+0.25), AZN: 69.29 (-0.81), FGEN: 20.38 (-1.01), QGEN: 24.71 (+0.21)
FDA clears Bayer antibiotic for the treatment of plague
Seeking Alpha - at Seeking Alpha - Fri May 08, 2:56PM CDT
Global Biochemical Sensors Market Forecast and Opportunities 2015-2020
M2 - Fri May 08, 9:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ctbmsf/global) has announced the addition of the "Global Biochemical Sensors Market Forecast and Opportunities, 2020" report to their offering. The global biochemical sensors market is projected to reach USD23.3 billion by 2020 Electrochemical, optical, thermal, and piezoelectric are the major types of biochemical sensors used across diverse applications. Growing health concerns, declining cost of devices coupled with miniaturization of biochemical sensing devices are few of the major factors expected to drive demand for biochemical sensors over the next five years. High accuracy, easy usability, higher sensitivity even at low analyte concentrations are boosting the adoption of biochemical sensors across diverse end use applications. Growing need for low-cost, easy to use, fast and reliable analytical tools has been paving the way for use of biochemical sensors for quantitative and qualitative determination of discrete analytes in clinical, agricultural, environmental, food and defense applications. Presently, biochemical sensors are being predominantly used in medical applications, however, their adoption is increasing in agricultural, nutritional and environmental sectors due to continuous emphasis on improving product quality and growing need to comply with legislative guidelines. Increasing research & development activities, rising government emphasis and increasing advancements in healthcare infrastructure are expected to drive the sales of biochemical sensors over next five years. Global Biochemical Sensors Market Forecast & Opportunities, 2020 discusses the following aspects about the global biochemical sensors market: - Global Biochemical Sensors Market Size, Share & Forecast - Segmental Analysis - By Product Type (Electro-chemical, Thermal, Piezoelectic, Optical, etc.) and By End Use (Medical, Environmental, Nutritional & Agricultural) - Regional Analysis (North America, Europe, Asia-Pacific & Rest of World) - Changing Market Trends & Emerging Opportunities - Competitive Landscape & Strategic Recommendations Market Trends & Developments - Development of Silicon Microsensors - Development of Optical Fibers - Automotive Biochemical Sensors Technology - Growing Demand of Personalized Medicine - Miniaturization of Biochemical sensors - Integration of Wireless Communications Systems - Mass Production of Biochemical sensors Competitive Landscape - Company Shares - Abbott Point of Care Inc - Smiths Medical Md, Inc - LifeSensors Inc - LifeScan Inc. - Medtronic plc - Boston Scientific Corporation - Nova Biomedical Corporation - Acon Laboratories, Inc - Bio-Rad Laboratories, Inc - Universal Biosensors, Inc - Bayer AG - Pharmaco-Kinesis Corporation - SensLab - BioDetection Instruments, Inc - Biosensor Laboratories Incorporated - ABTECH Scientific, Inc - NeuroSky, Inc. - Biosensors International Group, Ltd - Roche Diagnostics - Sysmex Corporation - YSI Life Sciences For more information visit http://www.researchandmarkets.com/research/ctbmsf/global
BSX: 17.85 (-0.06), MDT: 76.42 (+0.16)
Medivation, Jazz Q1 Reports Miss; Regeneron Beats
at Investor's Business Daily - Thu May 07, 5:43PM CDT
Rising biotech star Medivation started losing altitude in after-hours trading Thursday after its Q1 report missed estimates, in a day when several high-rated drug stocks reported. Medivation's (MDVN) earnings excluding one-time items totaled 17 cents...
MDVN: 122.90 (-0.47), ESRX: 87.37 (-0.09), JAZZ: 178.01 (+2.51), REGN: 489.01 (-2.42), CNCE: 14.13 (-0.05)
California Supreme Court says no to pharma's pay-for-delay deals
Seeking Alpha - at Seeking Alpha - Thu May 07, 4:30PM CDT
ABT: 48.71 (+0.04), TEVA: 60.23 (-0.99), ABBV: 65.99 (+0.02)
Regeneron Beats on Q1 Earnings, Eylea 2015 View Upped
Global Myocardial Infarction Pipeline Review 2015
M2 - Thu May 14, 5:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m6sc3q/myocardial) has announced the addition of the "Myocardial Infarction - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Myocardial Infarction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myocardial Infarction and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - A. Menarini Industrie Farmaceutiche Riunite Srl - Alligator Bioscience AB - AstraZeneca PLC - Athersys, Inc. - Bayer AG - CellProthera - Compugen Ltd. - CSL Limited - FibroGen, Inc. - Fina Biotech - Genextra S.p.a. - GlaxoSmithKline plc - GliaMed, Inc. - Hadasit Medical Research Services & Development Ltd - Lacer, S.A. - Lee's Pharmaceutical Holdings Limited - LegoChem Biosciences, Inc - LG Life Sciences, Ltd. - Ligand Pharmaceuticals, Inc. - Medestea Research & Production S.p.A. - Merck & Co., Inc. - Omni Bio Pharmaceutical Inc. - Pluristem Therapeutics Inc. - Polyphor Ltd. - Quantum Genomics SA - Recardio GmbH - Remedy Pharmaceuticals, Inc. - Targazyme, Inc. - Vicore Pharma AB - Zydus Cadila Healthcare Limited For more information visit http://www.researchandmarkets.com/research/m6sc3q/myocardial
PSTI: 2.68 (-0.01), MRK: 60.23 (+0.45), AZN: 69.29 (-0.81), CGEN: 6.45 (-0.03), FGEN: 20.38 (-1.01), GSK: 44.77 (-0.22), ATHX: 1.27 (-0.01)
Research and Markets: Global polyolefins Market 2015-2020 - Application Overview, Trends, Growth, Future, Opportunities, Challenges, Segmentation, Trends & Forecasts
Business Wire - Wed May 13, 9:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7pdr38/global) has announced the addition of the "Global polyolefins Market By Application Overview, Trends, Growth, Future, Opportunities, Challenges, Segmentation, Trends & Forecast 2015-2020" report to their offering.
DOW: 51.51 (+0.27)
Global polyolefins Market 2015-2020 - Application Overview, Trends, Growth, Future, Opportunities, Challenges, Segmentation, Trends & Forecasts
M2 - Wed May 13, 6:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nk9f5s/global) has announced the addition of the "Global polyolefins Market By Application Overview, Trends, Growth, Future, Opportunities, Challenges, Segmentation, Trends & Forecast 2015-2020" report to their offering. Extensive competitive and strategy analysis is covered in this report. Companies profiled include BASF, Dow Chemical Company, Bayer AG, Saudi Basic Industries Corporation (SABIC), LyondellBasell Industries, DuPont, Braskem, Aryasasol among others. The report forecast market growth and trends via applications, technologies and geographies from 2014 -2021. The popularity of polyolefins has been largely motivated due to its extremely diverse applications. Polyolefins are used in industries such as packaging, automotive, transportation, consumables, electronics, building, construction, etc., blow molding that includes blow molded bottles for juice, milk, motor oil, laundry detergents, etc. and fibers and tapes mostly used in building & construction, etc. Another motivating factor is the easy availability of raw materials and the huge demand from China. The growth in the industry is largely driven from packaging and construction industry. The industry has received a huge push from the demand from various sectors and the continuous innovation. Of these, innovations in packaging applications have resulted in adoption of polyolefins packaging materials in a big way. Food packaging that mostly comprises of thin walled containers and films, has found a huge market in both the developed and developing countries. The huge demand in Asia-Pacific market is one of the primary drivers for polyolefins industry. A number of companies have also established their presence in Asia-Pacific to meet the demand primarily from various industries in China. Key Topics Covered: Chapter 1. Executive Summary Chapter 2. Market Overview Chapter 3. Market Determinants Chapter 4. Market Segmentation Chapter 5. Sector Analysis Chapter 6. Competitive Intelligence Chapter 7. Market Share Analysis Chapter 8. Geography Analysis Chapter 9. Corporate Profiling - BASF - Dow Chemical Company - Bayer AG - Saudi Basic Industries Corporation (SABIC) - LyondellBasell Industries - DuPont - Braskem - Aryasasol - Indian Petrochemicals Corporation - Formosa Plastics - Akzo Nobel/Imperial Chemical Industries - Evonik Industries - Asahi Kasei - Toray Industries - Chevron Phillips - PPG Industries - Shin-Etsu Chemical - PTT Group - Cargill - Mitsubishi Chemical - Rogers Corporation - PolyOne Corporation - Lotte Chemical - Total Petrochemical - Hitachi Chemical - Arkema - Lanxess - INEOS For more information visit http://www.researchandmarkets.com/research/nk9f5s/global
POL: 40.19 (-0.50), ROG: 71.36 (+0.02), PPG: 231.70 (+2.90), DOW: 51.51 (+0.27)
Congestive Heart Failure - 2015 Pipeline Analysis Covers Some of the Hot Targets in Research for CHF Treatments
M2 - Mon May 11, 10:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zw4hvv/congestive_heart) has announced the addition of the "Congestive Heart Failure - Pipeline Analysis" report to their offering. Congestive Heart Failure (CHF) Pipeline Analysis gives comprehensive insight on the various drugs being developed for the treatment of CHF. The report covers all the drugs being developed in various development phases (Discovery to Phase 2 clinical). The pipeline focuses on disease modification and includes pharmacologic drugs, gene therapy, stem cell therapy and RNA-based therapeutics, but excludes symptom relief drugs like diuretics, acute treatments, angiotensins or thrombin inhibitors etc. This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative opportunities in the CHF Drug market. The report also provide strategic insights on medicines that are likely to have an impact on CHF treatment space and potentially alter standards of care in CHF in the foreseeable future. Current therapies focuses only to slow down the progression of the disease as more number of molecules are symptom relieving drugs, hence it provides a tremendous opportunity for upcoming therapies specific to CHF such as gene-based, stem cell-based and miRNA-based therapies, which reverses disease course and reduce the number of cardiac events. Companies Mentioned: - Bayer AG - Bioheart, Inc. - Celladon Corp - Coretherapix - Glaxosmithkline - Juventas Therapeutics - Merck & Co. - Miragen Therapeutics - Moderna Therapeutics - Nano Cor Therapeutics - ONO Pharmaceuticals For more information visit http://www.researchandmarkets.com/research/zw...tive_heart About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MRK: 60.23 (+0.45), CLDN: 2.18 (-0.17)
Can-Fite cleared to start CF102 Phase 2 trial in Europe for liver cancer
Seeking Alpha - at Seeking Alpha - Mon May 11, 7:29AM CDT
CANF: 2.33 (-0.01), AMGN: 162.36 (+0.38)
Regeneron Beats, Raises And Accelerates Its Late-Stage Product Development
DoctoRx - at Seeking Alpha - Mon May 11, 7:02AM CDT
PCYC: 255.42 (-0.50), ISIS: 62.55 (+0.10), AZN: 69.29 (-0.81), ABBV: 65.99 (+0.02), SNY: 50.52 (-0.27), REGN: 489.01 (-2.42), NVS: 103.75 (-0.15)
Week In Review: Xinbang Pharma Acquires Chinese Peptide Co. For $323 Million
ChinaBio Today - at Seeking Alpha - Sun May 10, 9:03AM CDT
Deals and Financings Guizhou Xinbang Pharmaceutical (SHE: 002390) paid $323 million to acquire Chinese Peptide Company, located in Hangzhou, from the nine companies that owned it. In addition, Xinbang raised as much as $106 million, which it will...
MACK: 12.66 (+0.34), PVCT: 0.87 (-0.01), CCM: 7.01 (+0.25), AZN: 69.29 (-0.81), FGEN: 20.38 (-1.01), QGEN: 24.71 (+0.21)
FDA clears Bayer antibiotic for the treatment of plague
Seeking Alpha - at Seeking Alpha - Fri May 08, 2:56PM CDT
Global Biochemical Sensors Market Forecast and Opportunities 2015-2020
M2 - Fri May 08, 9:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ctbmsf/global) has announced the addition of the "Global Biochemical Sensors Market Forecast and Opportunities, 2020" report to their offering. The global biochemical sensors market is projected to reach USD23.3 billion by 2020 Electrochemical, optical, thermal, and piezoelectric are the major types of biochemical sensors used across diverse applications. Growing health concerns, declining cost of devices coupled with miniaturization of biochemical sensing devices are few of the major factors expected to drive demand for biochemical sensors over the next five years. High accuracy, easy usability, higher sensitivity even at low analyte concentrations are boosting the adoption of biochemical sensors across diverse end use applications. Growing need for low-cost, easy to use, fast and reliable analytical tools has been paving the way for use of biochemical sensors for quantitative and qualitative determination of discrete analytes in clinical, agricultural, environmental, food and defense applications. Presently, biochemical sensors are being predominantly used in medical applications, however, their adoption is increasing in agricultural, nutritional and environmental sectors due to continuous emphasis on improving product quality and growing need to comply with legislative guidelines. Increasing research & development activities, rising government emphasis and increasing advancements in healthcare infrastructure are expected to drive the sales of biochemical sensors over next five years. Global Biochemical Sensors Market Forecast & Opportunities, 2020 discusses the following aspects about the global biochemical sensors market: - Global Biochemical Sensors Market Size, Share & Forecast - Segmental Analysis - By Product Type (Electro-chemical, Thermal, Piezoelectic, Optical, etc.) and By End Use (Medical, Environmental, Nutritional & Agricultural) - Regional Analysis (North America, Europe, Asia-Pacific & Rest of World) - Changing Market Trends & Emerging Opportunities - Competitive Landscape & Strategic Recommendations Market Trends & Developments - Development of Silicon Microsensors - Development of Optical Fibers - Automotive Biochemical Sensors Technology - Growing Demand of Personalized Medicine - Miniaturization of Biochemical sensors - Integration of Wireless Communications Systems - Mass Production of Biochemical sensors Competitive Landscape - Company Shares - Abbott Point of Care Inc - Smiths Medical Md, Inc - LifeSensors Inc - LifeScan Inc. - Medtronic plc - Boston Scientific Corporation - Nova Biomedical Corporation - Acon Laboratories, Inc - Bio-Rad Laboratories, Inc - Universal Biosensors, Inc - Bayer AG - Pharmaco-Kinesis Corporation - SensLab - BioDetection Instruments, Inc - Biosensor Laboratories Incorporated - ABTECH Scientific, Inc - NeuroSky, Inc. - Biosensors International Group, Ltd - Roche Diagnostics - Sysmex Corporation - YSI Life Sciences For more information visit http://www.researchandmarkets.com/research/ctbmsf/global
BSX: 17.85 (-0.06), MDT: 76.42 (+0.16)
Medivation, Jazz Q1 Reports Miss; Regeneron Beats
at Investor's Business Daily - Thu May 07, 5:43PM CDT
Rising biotech star Medivation started losing altitude in after-hours trading Thursday after its Q1 report missed estimates, in a day when several high-rated drug stocks reported. Medivation's (MDVN) earnings excluding one-time items totaled 17 cents...
MDVN: 122.90 (-0.47), ESRX: 87.37 (-0.09), JAZZ: 178.01 (+2.51), REGN: 489.01 (-2.42), CNCE: 14.13 (-0.05)
California Supreme Court says no to pharma's pay-for-delay deals
Seeking Alpha - at Seeking Alpha - Thu May 07, 4:30PM CDT
ABT: 48.71 (+0.04), TEVA: 60.23 (-0.99), ABBV: 65.99 (+0.02)
Regeneron Beats on Q1 Earnings, Eylea 2015 View Upped
